PharmaMar presents encouraging results at ASCO for Small Cell Lung Cancer PR Newswire MADRID, June 4, 2024...
Life Science Alliance journal publishes results of plitidepsin in patients with COVID-19, which includes additional data on its antiviral...
PharmaMar signs a new licensing and commercialization agreement with Eczacibasi for lurbinectedin in Turkey PR Newswire Madrid, Dec. 22, 2021...
PharmaMar and Jazz Pharmaceuticals announce initiation of confirmatory phase III clinical trial of Zepzelca® (lurbinectedin) for the treatment of...
PharmaMar signs a licensing and commercialization agreement with Lotus Pharmaceutical for lurbinectedin in Taiwan PR Newswire MADRID, Nov. 11...
PharmaMar Has Announced That the Spanish Medicines Agency Has Authorized the APLICOV-PC Clinical Trial With...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.